16 results on '"Rosner, Bernard"'
Search Results
2. Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality.
- Author
-
Yang Hu, Geng Zong, Gang Liu, Wang, Molin, Rosner, Bernard, An Pan, Willett, Walter C., Manson, JoAnn E., Hu, Frank B., Qi Sun, Hu, Yang, Zong, Geng, Liu, Gang, Pan, An, and Sun, Qi
- Subjects
- *
CARDIOVASCULAR disease prevention , *CAUSES of death , *LONGITUDINAL method , *TYPE 2 diabetes , *RESEARCH funding , *SMOKING cessation , *WEIGHT gain , *PROPORTIONAL hazards models ,CARDIOVASCULAR disease related mortality - Abstract
Background: Whether weight gain after smoking cessation attenuates the health benefits of quitting is unclear.Methods: In three cohort studies involving men and women in the United States, we identified those who had reported quitting smoking and we prospectively assessed changes in smoking status and body weight. We estimated risks of type 2 diabetes, death from cardiovascular disease, and death from any cause among those who had reported quitting smoking, according to weight changes after smoking cessation.Results: The risk of type 2 diabetes was higher among recent quitters (2 to 6 years since smoking cessation) than among current smokers (hazard ratio, 1.22; 95% confidence interval [CI], 1.12 to 1.32). The risk peaked 5 to 7 years after quitting and then gradually decreased. The temporary increase in the risk of type 2 diabetes was directly proportional to weight gain, and the risk was not increased among quitters without weight gain (P<0.001 for interaction). In contrast, quitters did not have a temporary increase in mortality, regardless of weight change after quitting. As compared with current smokers, the hazard ratios for death from cardiovascular disease were 0.69 (95% CI, 0.54 to 0.88) among recent quitters without weight gain, 0.47 (95% CI, 0.35 to 0.63) among those with weight gain of 0.1 to 5.0 kg, 0.25 (95% CI, 0.15 to 0.42) among those with weight gain of 5.1 to 10.0 kg, 0.33 (95% CI, 0.18 to 0.60) among those with weight gain of more than 10.0 kg, and 0.50 (95% CI, 0.46 to 0.55) among longer-term quitters (>6 years since smoking cessation). Similar associations were observed for death from any cause.Conclusions: Smoking cessation that was accompanied by substantial weight gain was associated with an increased short-term risk of type 2 diabetes but did not mitigate the benefits of quitting smoking on reducing cardiovascular and all-cause mortality. (Funded by the National Institutes of Health.). [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
3. Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy.
- Author
-
Nishihara, Reiko, Wu, Kana, Lochhead, Paul, Morikawa, Teppei, Xiaoyun Liao, Zhi Rong Qian, Inamura, Kentaro, Kim, Sun A., Kuchiba, Aya, Yamauchi, Mai, Imamura, Yu, Willett, Walter C., Rosner, Bernard A., Fuchs, Charles S., Giovannucci, Edward, Ogino, Shuji, and Chan, Andrew T.
- Subjects
- *
COLON cancer , *MORTALITY , *ENDOSCOPY , *DISEASE research , *CANCER - Abstract
The article discusses research on an incidence of colorectal cancer and mortality following lower endoscopy. Topics discussed include sigmoidoscopy, colonoscopy, and cancer of the distal colorectum. Also mentioned are the hazard ratios for colorectal cancer, ulcerative colitis, and familial polyposis syndromes.
- Published
- 2013
- Full Text
- View/download PDF
4. Performance of Common Genetic Variants in Breast-Cancer Risk Models.
- Author
-
Wacholder, Sholom, Hartge, Patricia, Prentice, Ross, Garcia-Closas, Montserrat, Feigelson, Heather Spencer, Diver, W. Ryan, Thun, Michael J., Cox, David G., Hankinson, Susan E., Kraft, Peter, Rosner, Bernard, Berg, Christine D., Brinton, Louise A., Lissowska, Jolanta, Sherman, Mark E., Chlebowski, Rowan, Kooperberg, Charles, Jackson, Rebecca D., Buckman, Dennis W., and Hui, Peter
- Subjects
- *
BREAST cancer , *CANCER risk factors , *GENETICS , *CANCER in women , *CANCER patients , *WOMEN'S health - Abstract
Background: Genomewide association studies have identified multiple genetic variants associated with breast cancer. The extent to which these variants add to existing risk-assessment models is unknown. Methods: We used information on traditional risk factors and 10 common genetic variants associated with breast cancer in 5590 case subjects and 5998 control subjects, 50 to 79 years of age, from four U.S. cohort studies and one case–control study from Poland to fit models of the absolute risk of breast cancer. With the use of receiver-operating-characteristic curve analysis, we calculated the area under the curve (AUC) as a measure of discrimination. By definition, random classification of case and control subjects provides an AUC of 50%; perfect classification provides an AUC of 100%. We calculated the fraction of case subjects in quintiles of estimated absolute risk after the addition of genetic variants to the traditional risk model. Results: The AUC for a risk model with age, study and entry year, and four traditional risk factors was 58.0%; with the addition of 10 genetic variants, the AUC was 61.8%. About half the case subjects (47.2%) were in the same quintile of risk as in a model without genetic variants; 32.5% were in a higher quintile, and 20.4% were in a lower quintile. Conclusions: The inclusion of newly discovered genetic factors modestly improved the performance of risk models for breast cancer. The level of predicted breast-cancer risk among most women changed little after the addition of currently available genetic information. N Engl J Med 2010;362:986-93. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
5. Nut Consumption and Mortality.
- Author
-
Elin, Ronald J., Kopel, Eran, Kivity, Shaye, Sidi, Yechezkel, Ying Bao, Rosner, Bernard A., and Fuchs, Charles S.
- Subjects
- *
FOOD habits research , *NUTS , *MORTALITY - Abstract
Letters to the editor are presented in response to the study by Bao and colleagues on the inverse association between nut consumption and mortality in the November 21, 2013 issue.
- Published
- 2014
- Full Text
- View/download PDF
6. Extended Work Shifts and the Risk of Motor Vehicle Crashes among Interns.
- Author
-
Barger, Laura K., Cade, Brian E., Ayas, Najib T., Cronin, John W., Rosner, Bernard, Speizer, Frank E., and Czeisler, Charles A.
- Subjects
- *
SLEEP deprivation , *WORKING hours , *INTERNS (Medicine) , *TRAFFIC accidents , *SLEEP physiology , *MEDICAL education policy , *GRADUATE medical education , *HEALTH outcome assessment - Abstract
Background: Long work hours and work shifts of an extended duration (≥24 hours) remain a hallmark of medical education in the United States. Yet their effect on health and safety has not been evaluated with the use of validated measures. Methods: We conducted a prospective nationwide, Web-based survey in which 2737 residents in their first postgraduate year (interns) completed 17,003 monthly reports that provided detailed information about work hours, work shifts of an extended duration, documented motor vehicle crashes, near-miss incidents, and incidents involving involuntary sleeping. Results: The odds ratios for reporting a motor vehicle crash and for reporting a near-miss incident after an extended work shift, as compared with a shift that was not of extended duration, were 2.3 (95 percent confidence interval, 1.6 to 3.3) and 5.9 (95 percent confidence interval, 5.4 to 6.3), respectively. In a prospective analysis, every extended work shift that was scheduled in a month increased the monthly risk of a motor vehicle crash by 9.1 percent (95 percent confidence interval, 3.4 to 14.7 percent) and increased the monthly risk of a crash during the commute from work by 16.2 percent (95 percent confidence interval, 7.8 to 24.7 percent). In months in which interns worked five or more extended shifts, the risk that they would fall asleep while driving or while stopped in traffic was significantly increased (odds ratios, 2.39 [95 percent confidence interval, 2.31 to 2.46] and 3.69 [95 percent confidence interval, 3.60 to 3.77], respectively). Conclusions: Extended-duration work shifts, which are currently sanctioned by the Accreditation Council for Graduate Medical Education, pose safety hazards for interns. These results have implications for medical residency programs, which routinely schedule physicians to work more than 24 consecutive hours. N Engl J Med 2005;352:125-34. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
7. Dietary Fiber and the Risk of Colorectal Cancer and Adenoma in Women.
- Author
-
Fuchs, Charles S., Giovannucci, Edward L., Colditz, Graham A., Hunter, David J., Stampfer, Meir J., Rosner, Bernard, Speizer, Frank E., and Willett, Walter C.
- Subjects
- *
COLON cancer prevention , *ADENOMA , *FIBER content of food , *NUTRITION , *HEALTH - Abstract
Background: A high intake of dietary fiber has been thought to reduce the risk of colorectal cancer and adenoma. Methods: We conducted a prospective study of 88,757 women, who were 34 to 59 years old and had no history of cancer, inflammatory bowel disease, or familial polyposis, who completed a dietary questionnaire in 1980. During a 16-year follow-up period, 787 cases of colorectal cancer were documented. In addition, 1012 patients with adenomas of the distal colon and rectum were found among 27,530 participants who underwent endoscopy during the follow-up period. Results: After adjustment for age, established risk factors, and total energy intake, we found no association between the intake of dietary fiber and the risk of colorectal cancer; the relative risk for the highest as compared with the lowest quintile group with respect to fiber intake was 0.95 (95 percent confidence interval, 0.73 to 1.25). No protective effect of dietary fiber was observed when we omitted adjustment for total energy intake, when events during the first six years of follow-up were excluded, or when we excluded women who altered their fiber intake during the follow-up period. No significant association between fiber intake and the risk of colorectal adenoma was found. Conclusions: Our data do not support the existence of an important protective effect of dietary fiber against colorectal cancer or adenoma. (N Engl J Med 1999;340:169-76.) [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
8. Dietary Fat Intake and the Risk of Coronary Heart Disease in Women.
- Author
-
Hu, Frank B., Stampfer, Meir J., Manson, JoAnn E., Rimm, Eric, Colditz, Graham A., Rosner, Bernard A., Hennekens, Charles H., and Willett, Walter C.
- Subjects
- *
CORONARY disease , *FAT , *UNSATURATED fatty acids , *HEALTH ,SEX differences (Biology) - Abstract
Background: The relation between dietary intake of specific types of fat, particularly trans unsaturated fat, and the risk of coronary disease remains unclear. We therefore studied this relation in women enrolled in the Nurses' Health Study. Methods: We prospectively studied 80,082 women who were 34 to 59 years of age and had no known coronary disease, stroke, cancer, hypercholesterolemia, or diabetes in 1980. Information on diet was obtained at base line and updated during follow-up by means of validated questionnaires. During 14 years of follow-up, we documented 939 cases of nonfatal myocardial infarction or death from coronary heart disease. Multivariate analyses included age, smoking status, total energy intake, dietary cholesterol intake, percentages of energy obtained from protein and specific types of fat, and other risk factors. Results: Each increase of 5 percent of energy intake from saturated fat, as compared with equivalent energy intake from carbohydrates, was associated with a 17 percent increase in the risk of coronary disease (relative risk, 1.17; 95 percent confidence interval, 0.97 to 1.41; P = 0.10). As compared with equivalent energy from carbohydrates, the relative risk for a 2 percent increment in energy intake from trans unsaturated fat was 1.93 (95 percent confidence interval, 1.43 to 2.61; P<0.001); that for a 5 percent increment in energy from monounsaturated fat was 0.81 (95 percent confidence interval, 0.65 to 1.00; P = 0.05); and that for a 5 percent increment in energy from polyunsaturated fat was 0.62 (95 percent confidence interval, 0.46 to 0.85; P = 0.003). Total fat intake was not significantly related to the risk of coronary disease (for a 5 percent increase in energy from fat, the relative risk was 1.02; 95 percent confidence interval, 0.97 to 1.07; P = 0.55). We estimated that the replacement of 5 percent of energy from saturated fat with energy from unsaturated fats would reduce risk by 42 percent (95 percent confidence interval, 23 to 56; P<0.001) and that the replacement of 2 percent of energy from trans fat with energy from unhydrogenated, unsaturated fats would reduce risk by 53 percent (95 percent confidence interval, 34 to 67; P<0.001). Conclusions: Our findings suggest that replacing saturated and trans unsaturated fats with unhydrogenated monounsaturated and polyunsaturated fats is more effective in preventing coronary heart disease in women than reducing overall fat intake. (N Engl J Med 1997;337:1491-9.) [ABSTRACT FROM AUTHOR]
- Published
- 1997
- Full Text
- View/download PDF
9. Postmenopausal Hormone Therapy and Mortality.
- Author
-
Grodstein, Francine, Stampfer, Meir J., Colditz, Graham A., Willett, Walter C., Manson, JoAnn E., Joffe, Marshall, Rosner, Bernard, Fuchs, Charles, Hankinson, Susan E., Hunter, David J., Hennekens, Charles H., and Speizer, Frank E.
- Subjects
- *
HORMONE therapy for menopause , *WOMEN'S health - Abstract
Background: Postmenopausal hormone therapy has both benefits and hazards, including decreased risks of osteoporosis and cardiovascular disease and an increased risk of breast cancer. Methods: We examined the relation between the use of postmenopausal hormones and mortality among participants in the Nurses' Health Study, who were 30 to 55 years of age at base line in 1976. Data were collected by biennial questionnaires beginning in 1976 and continuing through 1992. We documented 3637 deaths from 1976 to 1994. Each participant who died was matched with 10 controls alive at the time of her death. For each death, we defined the subject's hormone status according to the last biennial questionnaire before her death or before the diagnosis of the fatal disease; this reduced bias caused by the discontinuation of hormone use between the time of diagnosis of a potentially fatal disease and death. Results: After adjustment for confounding variables, current hormone users had a lower risk of death (relative risk, 0.63; 95 percent confidence interval, 0.56 to 0.70) than subjects who had never taken hormones; however, the apparent benefit decreased with long-term use (relative risk, 0.80; 0.67 to 0.96, after 10 or more years) because of an increase in mortality from breast cancer among long-term hormone users. Current hormone users with coronary risk factors (69 percent of the women) had the largest reduction in mortality (relative risk, 0.51; 95 percent confidence interval, 0.45 to 0.57), with substantially less benefit for those at low risk (13 percent of the women; relative risk, 0.89; 95 percent confidence interval, 0.62 to 1.28). Conclusions: On average, mortality among women who use postmenopausal hormones is lower than among nonusers; however, the survival benefit diminishes with longer duration of use and is lower for women at low risk for coronary disease. (N Engl J Med 1997;336:1769-75.) [ABSTRACT FROM AUTHOR]
- Published
- 1997
- Full Text
- View/download PDF
10. Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease.
- Author
-
Grodstein, Francine, Stampfer, Meir J., Manson, JoAnn E., Colditz, Graham A., Willett, Walter C., Rosner, Bernard, Speizer, Frank E., and Hennekens, Charles H.
- Subjects
- *
ESTROGEN replacement therapy , *CARDIOVASCULAR disease prevention - Abstract
Background: Estrogen therapy in postmenopausal women has been associated with a decreased risk of heart disease. There is little information, however, about the effect of combined estrogen and progestin therapy on the risk of cardiovascular disease. Methods: We examined the relation between cardiovascular disease and postmenopausal hormone therapy during up to 16 years of follow-up in 59,337 women from the Nurses' Health Study, who were 30 to 55 years of age at base line. Information on hormone use was ascertained with biennial questionnaires. From 1976 to 1992, we documented 770 cases of myocardial infarction or death from coronary disease in this group and 572 strokes. Proportional-hazards models were used to calculate relative risks and 95 percent confidence intervals, adjusted for confounding variables. Results: We observed a marked decrease in the risk of major coronary heart disease among women who took estrogen with progestin, as compared with the risk among women who did not use hormones (multivariate adjusted relative risk, 0.39; 95 percent confidence interval, 0.19 to 0.78) or estrogen alone (relative risk, 0.60; 95 percent confidence interval, 0.43 to 0.83). However, there was no significant association between stroke and use of combined hormones (multivariate adjusted relative risk, 1.09; 95 percent confidence interval, 0.66 to 1.80) or estrogen alone (relative risk, 1.27; 95 percent confidence interval, 0.95 to 1.69). Conclusions: The addition of progestin does not appear to attenuate the cardioprotective effects of postmenopausal estrogen therapy. (N Engl J Med 1996;335:453-61.) [ABSTRACT FROM AUTHOR]
- Published
- 1996
- Full Text
- View/download PDF
11. Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease.
- Author
-
Hennekens, Charles H., Buring, Julie E., Manson, JoAnn E., Stampfer, Meir, Rosner, Bernard, Cook, Nancy R., Belanger, Charlene, LaMotte, Frances, Gaziano, J. Michael, Ridker, Paul M., Willett, Walter, and Peto, Richard
- Subjects
- *
CLINICAL trial registries , *CAROTENES , *DIETARY supplements , *HEART diseases , *HEART disease risk factors , *DIET in disease , *CANCER risk factors , *CAUSES of death , *CIGARETTE smokers , *DISEASE susceptibility ,MYOCARDIAL infarction-related mortality - Abstract
Background: Observational studies suggest that people who consume more fruits and vegetables containing beta carotene have somewhat lower risks of cancer and cardiovascular disease, and earlier basic research suggested plausible mechanisms. Because large randomized trials of long duration were necessary to test this hypothesis directly, we conducted a trial of beta carotene supplementation. Methods: In a randomized, double-blind, placebo-controlled trial of beta carotene (50 mg on alternate days), we enrolled 22,071 male physicians, 40 to 84 years of age, in the United States; 11 percent were current smokers and 39 percent were former smokers at the beginning of the study in 1982. By December 31, 1995, the scheduled end of the study, fewer than 1 percent had been lost to follow-up, and compliance was 78 percent in the group that received beta carotene. Results: Among 11,036 physicians randomly assigned to receive beta carotene and 11,035 assigned to receive placebo, there were virtually no early or late differences in the overall incidence of malignant neoplasms or cardiovascular disease, or in overall mortality. In the beta carotene group, 1273 men had any malignant neoplasm (except nonmelanoma skin cancer), as compared with 1293 in the placebo group (relative risk, 0.98; 95 percent confidence interval, 0.91 to 1.06). There were also no significant differences in the number of cases of lung cancer (82 in the beta carotene group vs. 88 in the placebo group); the number of deaths from cancer (386 vs. 380), deaths from any cause (979 vs. 968), or deaths from cardiovascular disease (338 vs. 313); the number of men with myocardial infarction (468 vs. 489); the number with stroke (367 vs. 382); or the number with any one of the previous three end points (967 vs. 972). Among current and former smokers, there were also no significant early or late differences in any of these end points. Conclusions: In this trial among healthy men, 12 years of supplementation with beta carotene produced neither benefit nor harm in terms of the incidence of malignant neoplasms, cardiovascular disease, or death from all causes. (N Engl J Med 1996;334:1145-9.) [ABSTRACT FROM AUTHOR]
- Published
- 1996
- Full Text
- View/download PDF
12. The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women.
- Author
-
Colditz, Graham A., Hankinson, Susan E., Hunter, David J., Willett, Walter C., Manson, JoAnn E., Stampfer, Meir J., Hennekens, Charles, Rosner, Bernard, and Speizer, Frank E.
- Subjects
- *
HORMONE therapy for menopause , *BREAST cancer risk factors - Abstract
Background: The effect of adding progestins to estrogen therapy on the risk of breast cancer in postmenopausal women is controversial. Methods: To quantify the relation between the use of hormones and the risk of breast cancer in postmenopausal women, we extended our follow-up of the participants in the Nurses' Health Study to 1992. The women were asked to complete questionnaires every two years to update information on their menopausal status, use of estrogen and progestin preparations, and any diagnosis of breast cancer. During 725,550 person-years of follow-up, we documented 1935 cases of newly diagnosed invasive breast cancer. Results: The risk of breast cancer was significantly increased among women who were currently using estrogen alone (relative risk, 1.32; 95 percent confidence interval, 1.14 to 1.54) or estrogen plus progestin (relative risk, 1.41; 95 percent confidence interval, 1.15 to 1.74), as compared with postmenopausal women who had never used hormones. Women currently taking hormones who had used such therapy for 5 to 9 years had an adjusted relative risk of breast cancer of 1.46 (95 percent confidence interval, 1.22 to 1.74), as did those currently using hormones who had done so for a total of 10 or more years (relative risk, 1.46; 95 percent confidence interval, 1.20 to 1.76). The increased risk of breast cancer associated with five or more years of postmenopausal hormone therapy was greater among older women (relative risk for women 60 to 64 years old, 1.71; 95 percent confidence interval, 1.34 to 2.18). The relative risk of death due to breast cancer was 1.45 (95 percent confidence interval, 1.01 to 2.09) among women who had taken estrogen for five or more years. Conclusions: The addition of progestins to estrogen therapy does not reduce the risk of breast cancer among postmenopausal women. The substantial increase in the risk of breast cancer among older women who take hormones suggests that the trade-offs between risks and benefits should be carefully assessed. (N Engl J Med 1995;332:1589-93.) [ABSTRACT FROM AUTHOR]
- Published
- 1995
- Full Text
- View/download PDF
13. Alcohol Consumption and Mortality among Women.
- Author
-
Fuchs, Charles S., Stampfer, Meir J., Colditz, Graham A., Giovannucci, Edward L., Manson, JoAnn E., Kawachi, Ichiro, Hunter, David J., Hankinson, Susan E., Hennekens, Charles H., Rosner, Bernard, Speizer, Frank E., and Willett, Walter C.
- Subjects
- *
WOMEN , *ALCOHOL drinking , *HEALTH , *MORTALITY - Abstract
Background: Studies in men suggest that light-to-moderate alcohol intake is associated with a reduction in overall mortality, due primarily to a reduced risk of coronary heart disease. Among women with similar levels of alcohol consumption, an increased risk of breast cancer has been noted that complicates the balance of risks and benefits. Methods: We conducted a prospective study among 85,709 women, 34 to 59 years of age and without a history of myocardial infarction, angina, stroke, or cancer, who completed a dietary questionnaire in 1980. During the 12-year follow-up period, 2658 deaths were documented. Results: The relative risks of death in drinkers as compared with nondrinkers were 0.83 (95 percent confidence interval, 0.74 to 0.93) for women who consumed 1.5 to 4.9 g of alcohol per day (one to three drinks per week), 0.88 (95 percent confidence interval, 0.80 to 0.98) for those who consumed 5.0 to 29.9 g per day, and 1.19 (95 percent confidence interval, 1.02 to 1.38) for those who consumed 30 g or more per day, after adjustment for other predictors of mortality. Light-to-moderate drinking (1.5 to 29.9 g per day) was associated with a decreased risk of death from cardiovascular disease; heavier drinking was associated with an increased risk of death from other causes, particularly breast cancer and cirrhosis. The benefit associated with light-to-moderate drinking was most apparent among women with risk factors for coronary heart disease and those 50 years of age or older. Conclusions: Among women, light-to-moderate alcohol consumption is associated with a reduced mortality rate, but this apparent survival benefit appears largely confined to women at greater risk for coronary heart disease. (N Engl J Med 1995;332:1245-50.) [ABSTRACT FROM AUTHOR]
- Published
- 1995
- Full Text
- View/download PDF
14. Moderate Alcohol Intake, Increased Levels of High-Density Lipoprotein and Its Subfractions, and Decreased Risk of Myocardial Infarction.
- Author
-
Gaziano, J. Michael, Buring, Julie E., Breslow, Jan L., Goldhaber, Samuel Z., Rosner, Bernard, VanDenburgh, Martin, Willett, Walter, and Hennekens, Charles H.
- Subjects
- *
THERAPEUTIC use of alcohol , *LIPOPROTEINS , *CORONARY disease , *BLOOD plasma , *MEDICAL research , *HOSPITALS ,MYOCARDIAL infarction diagnosis - Abstract
Background: Previous studies have suggested that moderate alcohol intake exerts a protective effect against coronary heart disease. Alterations in plasma lipoprotein levels represent one plausible mechanism of this apparent protective effect. Methods: We therefore examined the interrelation among alcohol consumption, plasma lipoprotein levels, and the risk of myocardial infarction in 340 patients who had had myocardial infarctions and an equal number of age- and sex-matched controls. The case patients were men or women less than 76 years of age with no history of coronary disease who were discharged from one of six hospitals in the Boston area with a diagnosis of a confirmed myocardial infarction. Alcohol consumption was estimated by means of a food-frequency questionnaire. Results: We observed a significant inverse association between alcohol consumption and the risk of myocardial infarction (P for trend, <0.001 after control for known coronary risk factors). In multivariate analyses, the relative risk for the highest intake category (subjects who consumed three or more drinks per day) as compared with the lowest (those who had less than one drink a month) was 0.45 (95 percent confidence interval, 0.26 to 0.80). The levels of total high-density lipoprotein cholesterol (HDL) and its HDL2 and HDL3 subfractions were strongly associated with alcohol consumption (P for trend, <0.001 for each). The addition of HDL or either of its subfractions to the multivariate model substantially reduced the inverse association between alcohol intake and myocardial infarction, whereas the addition of the other plasma lipid measurements did not materially alter the relation. Conclusions: These data confirm the inverse association of moderate alcohol intake with the risk of myocardial infarction and support the view that the effect is mediated, in large part, by increases in both HDL2 and HDL3. (N Engl J Med 1993;329:1829-34.) [ABSTRACT FROM AUTHOR]
- Published
- 1993
- Full Text
- View/download PDF
15. A Prospective Study of the Intake of Vitamins C, E, and A and the Risk of Breast Cancer.
- Author
-
Hunter, David J., Manson, JoAnn E., Colditz, Graham A., Stampfer, Meir J., Rosner, Bernard, Hennekens, Charles H., Speizer, Frank E., and Willett, Walter C.
- Subjects
- *
BREAST cancer , *ANTIOXIDANTS , *VITAMIN C , *VITAMIN E , *VITAMIN A , *CANCER patients , *CANCER in women , *WOMEN'S health , *CHEMICAL inhibitors - Abstract
Background: Although it has been hypothesized that large intakes of the antioxidant vitamins C, E, and A reduce the risk of breast cancer, few prospective data are available. Methods: We prospectively studied 89,494 women who were 34 to 59 years old in 1980 and who did not have diagnosed cancer. Their intakes of vitamins C, E, and A from foods and supplements were assessed at base line and in 1984 with the use of a validated semiquantitative food-frequency questionnaire. Results: Breast cancer was diagnosed in 1439 women during eight years of follow-up. After multivariate adjustment for known risk factors, the relative risk among women in the highest quintile group for intake of vitamin C as compared with the risk among those in the lowest quintile group was 1.03 (95 percent confidence interval, 0.87 to 1.21); for vitamin E, after vitamin A intake had been controlled for, the relative risk was 0.99 (95 percent confidence interval, 0.83 to 1.19). In contrast, among women in the highest quintile group for intake of total vitamin A the relative risk was 0.84 (95 percent confidence interval, 0.71 to 0.98; P for trend = 0.001). Among women in the lowest quintile group for intake of vitamin A from food, consumption of vitamin A from supplements was associated with a reduced risk (P = 0.03). The significant inverse association of vitamin A intake with the risk of breast cancer was also found on study of data based on the 1984 questionnaire and four years of follow-up. Conclusions: Large intakes of vitamin C or E did not protect women in our study from breast cancer. A low intake of vitamin A may increase the risk of this disease; any benefit of vitamin A supplements may be limited to women with diets low in vitamin A. (N Engl J Med 1993;329:234-40.) [ABSTRACT FROM AUTHOR]
- Published
- 1993
- Full Text
- View/download PDF
16. Vitamin E Consumption and the Risk of Coronary Disease in Women.
- Author
-
Stampfer, Meir J., Hennekens, Charles H., Manson, JoAnn E., Colditz, Graham A., Rosner, Bernard, and Willett, Walter C.
- Subjects
- *
VITAMIN research - Abstract
Background: Interest in the antioxidant vitamin E as a possible protective nutrient against coronary disease has intensified with the recognition that oxidized low-density lipoprotein may be involved in atherogenesis. Methods: In 1980, 87,245 female nurses 34 to 59 years of age who were free of diagnosed cardiovascular disease and cancer completed dietary questionnaires that assessed their consumption of a wide range of nutrients, including vitamin E. During follow-up of up to eight years (679,485 person-years) that was 97 percent complete, we documented 552 cases of major coronary disease (437 nonfatal myocardial infarctions and 115 deaths due to coronary disease). Results: As compared with women in the lowest fifth of the cohort with respect to vitamin E intake, those in the top fifth had a relative risk of major coronary disease of 0.66 (95 percent confidence interval, 0.50 to 0.87) after adjustment for age and smoking. Further adjustment for a variety of other coronary risk factors and nutrients, including other antioxidants, had little effect on the results. Most of the variability in intake and reduction in risk was attributable to vitamin E consumed as supplements. Women who took vitamin E supplements for short periods had little apparent benefit, but those who took them for more than two years had a relative risk of major coronary disease of 0.59 (95 percent confidence interval, 0.38 to 0.91) after adjustment for age, smoking status, risk factors for coronary disease, and use of other antioxidant nutrients (including multivitamins). Conclusions: Although these prospective data do not prove a cause-and-effect relation, they suggest that among middle-aged women the use of vitamin E supplements is associated with a reduced risk of coronary heart disease. Randomized trials of vitamin E in the primary and secondary prevention of coronary disease are being conducted; public policy recommendations about the widespread use of vitamin E should await the results of these trials. (N Engl J Med 1993;328:1444-9.) [ABSTRACT FROM AUTHOR]
- Published
- 1993
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.